OA10.06 A First-in-Human Phase 1 Trial of the EGFR-cMET Bispecific Antibody JNJ-61186372 in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)

Authors :: Matthew V. Lorenzi
M-J. Ahn
H.R. Kim
S.J. Lee
Roland Elmar Knoblauch
Z. Aguilar
Sylvie Laquerre
Byoung Chul Cho
S. Triantos
Nahor Haddish-Berhane
K. Park
Minsun Hong
M. Curtis
Dawn Millington
S. Chaplan
Source :: Journal of Thoracic Oncology. 13:S344-S345
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: 0301 basic medicine
Pulmonary and Respiratory Medicine
Bispecific antibody
business.industry
non-small cell lung cancer (NSCLC)
First in human
medicine.disease
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
Oncology
030220 oncology & carcinogenesis
Cancer research
Medicine
In patient
business

Full Text Access

Tools